<div id="readability-page-1"><h3>Claim 30% Off TipRanks</h3><ul><li>Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions </li><li> Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks </li></ul>An announcement from Aimei Health Technology Co., Ltd ( (AFJK) ) is now available. On April 17, 2026, Aimei Health Technology Co., Ltd received a Nasdaq notice stating it was non-compliant with listing rules after failing to file its Form 10‑K for the year ended Dec. 31, 2025, which had been due March 31 and for which it had lodged a late‑filing notice on April 1. The April 21, 2026 announcement confirms there is no immediate impact on the trading of its Nasdaq‑listed securities, but the company faces a potential delisting if it does not file the report or secure and execute an acceptable compliance plan within Nasdaq’s 60‑ to 180‑day remediation window. Under Nasdaq procedures, Aimei has 60 days from the April 17, 2026 notice either to file the overdue annual report or submit a remediation plan, with up to 180 days from the original due date available if the plan is accepted. The company says it is working to complete the filing and aims to regain compliance, a process closely watched by investors because prolonged non‑compliance or an unsuccessful appeal could ultimately jeopardize its Nasdaq listing and impair its ability to execute its blank check acquisition strategy. More about Aimei Health Technology Co., Ltd Aimei Health Technology Co., Ltd is a Cayman Islands‑incorporated blank check company formed to pursue a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses. While not restricted to any sector or geography, it plans to target companies focused on healthcare innovation, positioning itself as a special purpose acquisition vehicle in the health sector deal market. Average Trading Volume: 22,564 Technical Sentiment Signal: Strong Buy Current Market Cap: $313.4M Learn more about AFJK stock on TipRanks’ Stock Analysis page.</div>

AFJK

LABU

SBIO

Aimei Health Technology Co., Ltd (AFJK) has received a Nasdaq notice of non-compliance due to its failure to file the Form 10-K for the year ended December 31, 2025, which was due on March 31. The company has a 60 to 180-day window to file the overdue report or submit a compliance plan to avoid potential delisting. Aimei is working to regain compliance, which is crucial for its blank check acquisition strategy in the healthcare sector.

Aimei Health Faces Nasdaq Noncompliance Over Delayed 10-K